Annals
Established in 1927 by the American College of Physicians
:
Advanced search
A more recent version of this article appeared on July 17, 2007.
box Article
 arrow  Full Text of this article Free
space
 arrow  PDF of this article
(PDFs free after 6 months)
space
All Versions of this Article:
  arrow 147/2/128 (most recent)
  arrow 0000605-200707170-00172v1
 arrow  Figures/Tables List
space
 arrow  Recommendation summary
space
 arrow  CME course
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

CLINICAL GUIDELINES

Screening for Chlamydial Infection: U.S. Preventive Services Task Force Recommendation Statement

right arrow U.S. Preventive Services Task Force*

17 July 2007 | Volume 147 Issue 2

Description: Update of 2001 U.S. Preventive Services Task Force (USPSTF) recommendations about screening sexually active adolescents and adults for chlamydial infection.

Methods: The USPSTF weighed the benefits (improved fertility, pregnancy outcomes, and infection transmission) and harms (anxiety, relationship problems, and unnecessary treatment of false positives) of chlamydial screening identified in their 2001 recommendations and the accompanying systematic review of English- language articles published between July 2000 and July 2005.

Recommendations: Screen for chlamydial infection in all sexually active nonpregnant young women age 24 years or younger and for older nonpregnant women who are at increased risk. (A recommendation)

Screen for chlamydial infection in all pregnant women age 24 years or younger and in older pregnant women who are at increased risk. (B recommendation)

Do not routinely screen for chlamydial infection in women age 25 years or older, regardless of whether they are pregnant, if they are not at increased risk. (C recommendation)

Current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydial infection for men. (I statement)

*For a list of the members of the U.S. Preventive Services Task Force, see the Appendix.

Author and Article Information
space

From the U.S. Preventive Services Task Force, Agency for Healthcare Research and Quality, Rockville, Maryland.

Disclaimer: Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services.

Potential Financial Conflicts of Interest: None disclosed.

Requests for Single Reprints: Reprints are available from the USPSTF Web site (www.preventiveservices.ahrq.gov) and from the Agency for Healthcare Research and Quality Publication Clearinghouse at 800-358-9295 or by e-mail at AHRQPubs{at}ahrq.hhs.gov.







 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 2007 by the American College of Physicians.